Sai Life Sciences
BSE 544306 · ISIN INE570L01029
4 stories, newest first.
- Sai Life Sciences to host Q2FY27 earnings conference call on 6 November 2026 at 11:00 AM IST
- Analyst suggested viewer could consider booking profits on Sai Life Sciences, though no standalone coverage available for formal recommendation
- Board Meeting on 5 November 2026 to Approve Q2 and H1 FY27 Unaudited Results
- Sai Life Sciences CFO discussed the company's shift from near-zero Big Pharma exposure in FY20 to 40% today in its discovery business, and rising China Plus One-driven diversification by large pharma to India
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.